Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.820 -0.530 (-22.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Enveric Biosciences Announces Closing of $8 Million Registered Direct and Private Placement Offerings, Priced at a Premium to Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday ↗
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. 
Via Benzinga
News headline image
Nasdaq Drops 100 Points; Crude Oil Rises Sharply ↗
U.S. stocks traded mostly lower toward the end of trading on Monday. 
Via Benzinga
News headline image
Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher ↗
U.S. stocks traded mostly higher midway through trading on Monday. 
Via Benzinga
News headline image
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. 
Via Benzinga
News headline image
Why U.S. Stocks Are Trading Mostly Higher; Chicago Fed National Activity Index Remains Unchanged ↗
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday. 
Via Benzinga
News headline image
Enveric Biosciences Stock Is Nosediving Today: What's Happening? ↗
Enveric Biosciences Inc (NASDAQ: ENVB) shares are trading lower by 21.84% to $7.55 Monday morning after the company announced an $8 million registered direct offering and private placement. 
Via Benzinga
News headline image
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
11 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
  
Via Benzinga
News headline image
Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Enveric Biosciences Announces Reverse Stock Split
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market ↗
Article by Jason Najum.  Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the... 
Via Benzinga
News headline image
Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
  
Via Benzinga
News headline image
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
10 Psychedelics CEOs To Pay Attention To In 2022 ↗
By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both... 
Via Benzinga
News headline image
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
EXCLUSIVE: NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics ↗
Enveric Biosciences (NASDAQ: ENVB), a biotech company working with cannabinoids and psychedelics, announced it will spin off its cannabinoid pipeline into a separate public company that will also be... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.